focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Responsibility for leaks are like responsibility for safeguarding any asset and rest with the Board. If physical assets were misused or misappropriated everyone understands the directors would ultimately responsible for securing them without us being concerned whether they were personally responsible for causing whatever the deficiency in security was. They are responsible to shareholders for safeguarding information in a similar way and should take steps to investigate the leak and eliminate it immediately. The fact that they don't damages the value of this investment to us and is indicative of the control environment and culture it has. I am going to sell quicker than I otherwise would.
It is a further disappointment that the leaks are not just the fact that something will happen, like a commercial update or placing, they are leaks of details specific to the subject like how much oil will be produced or how much the placing is for. It shows that the problem in UJO or parties it chooses to it work with is not on an incidental scale, it is practiced deliberate criminality practiced over years IMO.
It was a bit more than that otherwise it would have recovered more by now
Their indications to the market in six months before March 2020 were at odds with the audited result.
They had said turnaround project was on target during 2019 & how & why & that Profit before tax would be 265-295m,
On March 5th they reported an adjusted PBT of 275m with a lengthy spiel on how a lot had been achieved but more time would be needed accompanied by the auditors reporting a LOSS of 63m (derampers eh? or are auditors appointed to report independently to shareholders?)
The difference between the two basis of results was centrally costs such as head office increased (not covered in the spiel), amortisation, disposal costs, exceptional costs of restructuring & writing off system development costs of old systems and a new replacement system that hadn't worked yet. Its all stuff controlled by the BoD & especially the FD.
Covid was an explanation for saying why guidance on performance for YE2020 had to be removed. The free fall was in that context, them not being able to forecast with covid having been so far out without it & probably still without the system they had been developing for two years to forecast.
covid ought to have been an opportunity with LT contracts in place supporting some income & other 100 contacts to develop, instead it brought results down at half year unlike a competitor like G4S that came out with strong results.
The plan was to refocus business direction towards higher margin, higher value added work from consultancy & digitalisation. - both hard to sell standalone projects into competitive markets . Wins haven't flowed from the new focus. Instead they have come a low rate from the old base of lower margin, longer term contracts - such as the Navy training win announced today. CPI has also actually sold the last business with double digit profit it had hung the refocus spiel on ESS without filling the gap yet. Also, the FD has stood down, hopefully after achieving better control over those central, exceptional & systems development costs - wait to YE to find out, or not.
This is why a 1bn win hasn't rocketed the SP as might be expected & why recovery has not bounced as other fallers have.
More time required - v LTH.
GLA
Interesting read, it seems the virus could not have been engineered to be more dangerous.
Nevertheless, there were only 53 cases of Covid in China yesterday though the country is locked down in places for some reason.
I think that authorities are in disarray & planning for even more so someone has decided every effort should go into vaccination and leading to side lining testing including SNG, however illogical and wrong for public health that is. When panic is over, P3 will start but not on the time frame we (or SNG) expect.
Read piece below concerning international travel & covid tests wondering why it wouldn't have been one of the first controls to introduce? The country I live in closed its borders in March and suspended tourism which had contributed 25% of its GDP. Borders are strictly controlled now with mandatory Covid tests (3 or 4?) throughout state managed quarantine of two weeks. It is hard to believe the UK has only just introduced covid test requirements now. Why won't testing be a new norm for travel? It is in the Far East.
Guardian
"International travellers will need to show a negative Covid-19 test before being allowed into the UK, the government has announced, in a significant toughening of border controls to try to stem the spread of new coronavirus variants.
The new rules will take effect next week and apply to returning UK nationals as well as foreign citizens. Passengers will need to produce a test result taken less than 72 hours before boarding planes, boats or trains to the UK, and could be fined £500 in border spot checks without a negative result.
Arrivals will still need to quarantine for 10 days, even with a negative test, unless they are coming from one of the limited number of countries deemed low risk on the government’s travel corridor list."
yup, drop again today, no surprise
it feels like there is a limbo after a description like "imminent" was used 3 weeks ago.
"calm down", "it is very complicated" is at odds with the extraordinary surge in cases/potential for this treatment, progress made on other treatments and the chance that of something could be holding it up however illogical it might be like political drive for vaccination .
we are trying to buy or sell based on appetite for risk based on market information. PR is there to help with market information. perhaps "imminent" meant "in the next month/quarter or after X,Y or Z" or something else.
wow!
jnew, I'm invested here to my max and nil over there. your accusation of cross ramping just suggests a one less question for discussion & wasn't what it was about at all. the SP is stronger & more reliable for discussion IMO
oops
didn't mean treat, meant threat!
KR
How does this compare technologically with BRH's Paraytec?
BRH BB is full of confidence and speculation.
Is BRH a realistic test & possibly a treat do we think?
i don't know.
I was with someone with cytokine storm through their immunodeficiency which is why i invest here. Failing to breath brings a different perspective to a word like imminent.
The delay in SNG dosing can not be because of administrative difficulty in organising a test if Vaccines could be tested on a massive scale & scope, or even TILS could arrange a test in Brazil that reported bang on time earlier this week. The delay, presumably infinitely more frustrating to SNG than us, has a reason that we are not aware of.
Lets hope imminent turns out to be soon, at least in coming month, or perhaps there is a reason we do not understand for this treatment to have been blocked - in which case we should sell. no fault implied for SNG.
Could optics of testing a treatment undermine vaccine take up from a political point of view ir some equally disgusting side issue? This treatment should be tested not imminently, but immediately, for goodness sake!
maybe it has just gone cold in absence of pr from the company
Its either errie or an opportunity
perhaps there has been a leak of results
Its a frisky fomo just in case imminent comes soon
It seems to me that something held SNG further testing back since July. If it had been urgent, it wasn't as urgent as it might have been for some reason in the background.
Perhaps Phase 3 can testing will start now the AZN vaccine is approved & being rolled out or if it wasn't that, "imminently" in the next weeks.
Seems sensible, but how about false negative test results from LFT?
I found the bmj site had an estimate of 0.32% for Innova LFT (see below). If it was in the right order 3.2 lorry drivers in 1000 would be sent on their way having tested negative incorrectly. I wonder how many that would be in a day. They should PCR test them all & follow up the 3.2 false negatives.
https://www.bmj.com/content/371/bmj.m4469
The Innova SARS-CoV-2 Antigen Rapid Qualitative Test, which has been used in the Liverpool mass testing pilot to detect infections,2 is the first test to near completion of the four stage evaluation process. A report reviewed 8774 Innova tests carried out across a number of groups including outpatients with SARS-CoV-2, healthcare staff, armed forces personnel, and school students aged 11-18.
It found an overall sensitivity of 76.8%, but this rose to over 95% in individuals with high viral loads. The overall specificity of the test was reported as 99.68%, meaning a false positive rate of 0.32% (22/6967 tests.
I tried to sell 50% on the bell today with idea of buying back more shares but NT. I realised that I really wanted to increase my holding (notwithstanding new news or a placing) so expect there will be the opportunity over coming 10 months of "gravity" affecting SP as someone put it. What an exciting innovation. GLA
I think Newboy is right.
A few months shorter would have been exciting but acceptance of the application is the main priority.
How could they not want this asap with covid going on is beyond me personally & perhaps most of us in this forum.
I can't think that Boris, of all people, could disregard a treatment for cytokine storm if he heard of it having been in critical care & naming his newest born child after his doctor. I bet he has all too vivid a recollection of the peril it poses.